TNF and rheumatoid arthritis: Although this study was not designed to address a potential role of disease-modifying anti-rheumatic drugs including TNF-α inhibitors in the risk of osteoporotic fracture among RA patients, there is some evidence suggesting a beneficial effect of such drugs on bone loss [15,48,50].